Public consultation ARM 44: Request to reclassify Galpharm Hayfever Eye drops containing sodium cromoglicate 2% from Pharmacy (P) to General Sales List (GSL)

Consultation ARM 44 seeks your views on the reclassification from P to GSL of Galpharm Hayfever Eye drops containing sodium cromoglicate 2%.  The Reclassification Summary and Patient Information Leaflet as provided by the applicant company are displayed below.

Comments should be sent either by post to Veronica Popo in room 14-138, Market Towers, 1 Nine Elms Lane, London, SW8 5NQ or by e-mail (veronica.popo@mhra.gsi.gov.uk) to arrive by 8 October 2007.  Contributions received after that date cannot be included in the exercise.

Please inform us of your e-mail address if you wish to receive an electronic copy of all future consultations via e-mail.

To help informed debate on the issues raised by this consultation exercise, and within the terms of the Freedom of Information Act, the Agency intends to make copies of comments received publicly available.  Unless you state otherwise we will assume that you have no objections to your comments being publicly available on the Agency’s website.

› Online feedback form for ARM 44